Hydroxychloroquine continues to hit the headlines. After the publication of a study pointing out its ineffectiveness and its risks for the patients of Covid-19, the Minister of Health Olivier Véran asked on Saturday the High Council of Public Health (HCSP) to propose "within 48 hours a revision of the overriding prescription rules "for this processing.
>> LIVE - Coronavirus: follow the evolution of the situation on Saturday May 23
"Following the publication in The Lancet of a study alerting to the ineffectiveness and risks of certain treatments of Covid-19 including hydroxychloroquine, I asked the HCSP to analyze it and offer me within 48 hours a review of the overriding prescription rules, "the minister said in a tweet.
Over 200 studies around the world
Since the end of March in France, only patients with severe forms have been taking it in hospitals. But this seizure of the HCSCP should quickly change the situation. At the microphone of Europe 1, François Chast, member of the National Academy of Pharmacy, believes that this decision of the Minister of Health is above all a means of discouraging, even discouraging its use. "We know that, in this somewhat passionate area of hydroxychloroquine, it may be necessary to take somewhat coercive measures to ensure that this drug is no longer prescribed in the indication of the antiviral treatment of Covid ", he explains.
CORONAVIRUS ESSENTIALS
> Deconfinement: what could the new card presented on June 2 look like?
> Coronavirus: 5 mistakes not to make with your mask
> Coronavirus: the French Academy has decided, it will now be necessary to say "the" Covid-19
> Statistical corrections, rounded averages ... exceptional measures for the bac 2020
> Antibodies, reinfection, mutation: three questions on immunity to the coronavirus
> Why are French nurses among the lowest paid in Europe?
More than 200 studies are currently underway all over the world, to judge the effectiveness or not of chloroquine. That published in The Lancet consulted the files of 96,000 patients. Among them, 15,000 people had taken different dosages and combinations of the drug with others. Result: the risks of mortality would be 34 to 45% higher .